Supplementary Figure 1.jpg (823.7 kB)
Efficacy and safety of Rh-endostatin during peri-radiotherapy period in advanced non-small cell lung cancer patients - Supplementary Figure 1
figure
posted on 2022-01-06, 10:53 authored by Jianbo Zhu, Guangpeng Chen, Kai Niu, Yongdong Feng, Lijiao Xie, Si Qin, Zhongyu Wang, Jixi Li, Song Lang, Wenlei Zhuo, Zhengtang Chen, Jianguo Sun
Supplementary Figure 1. Efficacy and safety of Rh-endostatin during peri-radiotherapy period in advanced non-small cell lung cancer patients The outcomes of radiation pneumonitis (RP) in the Endostar group and the control group. The incidences of the RP remission, RP relapse and RP death were calculated based on the people who developed RP grade 2 and higher. The incidences of the pulmonary fibrosis were calculated based on the people who developed RP. |